Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK / STAT3 , MAPK / ERK , and AKT / mTOR signaling pathways in HepG2 cell line
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of
JAK
/
STAT3
,
MAPK
/
ERK
, and
AKT
/
mTOR
signaling pathways in
HepG2
cell line
Authors
Keywords
-
Journal
JOURNAL OF FOOD BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-07-22
DOI
10.1111/jfbc.14333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential thiosemicarbazone‐based enzyme inhibitors: Assessment of antiproliferative activity, metabolic enzyme inhibition properties, and molecular docking calculations
- (2022) Hasan Yakan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Simultaneous isolation and purification of cucurbitacin D and I from Ecballium elaterium (l.) A. Rich fruit juice
- (2020) Emir Tosun et al. Macedonian Journal of Chemistry and Chemical Engineering
- Cucurbitacin I induces apoptosis in ovarian cancer cells through oxidative stress and the p190B‑Rac1 signaling axis
- (2020) Ruli Li et al. Molecular Medicine Reports
- Mitogen-activated protein kinases are involved in cucurbitacin D-induced antitumor effects on adult T-cell leukemia cells
- (2020) Duo Wang et al. INVESTIGATIONAL NEW DRUGS
- Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
- (2020) Jae Hyung Park et al. Cells
- Preliminary phytochemical analysis and evaluation of in vitro antioxidant, antiproliferative, antidiabetic, and anticholinergics effects of endemic Gypsophila taxa from Turkey
- (2019) Ahmet Altay et al. JOURNAL OF FOOD BIOCHEMISTRY
- Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
- (2019) Yu Jiang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway
- (2019) Ruijie Sun et al. Cancer Medicine
- Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway
- (2018) Yinyun Ni et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cucurbitacin I induces cancer cell death through the endoplasmic reticulum stress pathway
- (2018) He Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase Alpha and Glucagon-Like Peptide-1 via Bitter Taste Receptor Signaling
- (2018) Kang-Hoon Kim et al. Frontiers in Pharmacology
- Separation of cucurbitane triterpenoids from bitter melon drinks and determination of partition coefficients using vortex-assisted dispersive liquid-phase microextraction followed by UHPLC analysis
- (2017) Shuang Hu et al. JOURNAL OF SEPARATION SCIENCE
- Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model
- (2017) Lucas Lourenço Marostica et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549
- (2015) Lucas Lourenço Marostica et al. CHEMICAL RESEARCH IN TOXICOLOGY
- SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
- (2015) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer
- (2015) JUNMIN SONG et al. ONCOLOGY REPORTS
- Hepatoprotective and proapoptotic effect of Ecballium elaterium on CCl4-induced hepatotoxicity in rats
- (2015) El Moataz Bellah El Naggar et al. Asian Pacific Journal of Tropical Medicine
- In Vitro and In Vivo Antitumor Activity of a Novel Semisynthetic Derivative of Cucurbitacin B
- (2015) Izabella T. Silva et al. PLoS One
- Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells
- (2014) Daniel R Premkumar et al. CANCER BIOLOGY & THERAPY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma
- (2014) Qiangjun Sui et al. JOURNAL OF IMMUNOLOGY
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma-Induced Immune Suppression
- (2013) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- Cellular and molecular mechanisms of hepatocellular carcinoma: an update
- (2012) Rajagopal N. Aravalli et al. ARCHIVES OF TOXICOLOGY
- The cucurbitacins E, D and I: Investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotransformation in man liver
- (2012) Suzanne Abbas et al. TOXICOLOGY LETTERS
- Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
- (2012) Masatoshi Kudo WORLD JOURNAL OF GASTROENTEROLOGY
- Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B Leukemic Cells
- (2011) Ganchimeg Ishdorj et al. BMC CANCER
- Anticancer activity of botanical compounds in ancient fermented beverages (Review)
- (2010) McGovern INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis
- (2010) G. Ishdorj et al. MOLECULAR CANCER THERAPEUTICS
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started